secwatch.observer — SEC 8-K summary
======================================

Issuer:     CATALYST PHARMACEUTICALS, INC. (CPRX)
CIK:        0001369568
Form:       8-K
Filed at:   2024-05-21T23:59:59+00:00
Accession:  0001193125-24-144049
Event type: other_material
Sentiment:  neutral
Materiality: 0.20
Item codes: 5.02, 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Catalyst Pharmaceuticals shareholders elect directors and approve incentive plan amendment
--------------------------------------------------------------------------------

- All seven director nominees elected: Daly, McEnany, Denkhaus, Harper, O'Keeffe, Thompson, Tierney.
- Amendment to 2018 Stock Incentive Plan approved with 86.8M for, 2.9M against, 168k abstained.
- Advisory vote on 2023 executive compensation passed: 84.2M for, 5.5M against, 182k abstained.
- Ratification of Grant Thornton as independent auditor approved: 99.6M for, 2.0M against, 79k abstained.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1369568/000119312524144049/0001193125-24-144049-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1369568/000119312524144049/d786039d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-144049

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer